Rush Md Anderson Cancer Center /ID# 274926 — Chicago, Illinois

Rush Md Anderson Cancer Center /ID# 274926 is a clinical research site located in Chicago, Illinois, United States 60607.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Rush Md Anderson Cancer Center /ID# 274926 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Md Anderson Cancer Center /ID# 274926?

Rush Md Anderson Cancer Center /ID# 274926 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Md Anderson Cancer Center /ID# 274926 conducted?

Rush Md Anderson Cancer Center /ID# 274926 has 1 clinical trials on record, with 1 currently active. Their work covers Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Rush Md Anderson Cancer Center /ID# 274926 accredited by Crixeo Health?

Rush Md Anderson Cancer Center /ID# 274926 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush Md Anderson Cancer Center /ID# 274926?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.